Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach

Background. Mitogen-activated protein kinase 3 (MAPK3) mediates the onset, progression, metastasis, drug resistance, and poor prognosis in various malignancies, including glioma, liver, ovarian, thyroid, lung, breast, gastric, and oral cancers. Negative regulation of MAPK3 expression using miRNAs ha...

Full description

Saved in:
Bibliographic Details
Main Authors: Amir Taherkhani, Parita Khodadadi, Lida Samie, Zahra Azadian, Zeynab Bayat
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:International Journal of Analytical Chemistry
Online Access:http://dx.doi.org/10.1155/2023/8899240
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546755229515776
author Amir Taherkhani
Parita Khodadadi
Lida Samie
Zahra Azadian
Zeynab Bayat
author_facet Amir Taherkhani
Parita Khodadadi
Lida Samie
Zahra Azadian
Zeynab Bayat
author_sort Amir Taherkhani
collection DOAJ
description Background. Mitogen-activated protein kinase 3 (MAPK3) mediates the onset, progression, metastasis, drug resistance, and poor prognosis in various malignancies, including glioma, liver, ovarian, thyroid, lung, breast, gastric, and oral cancers. Negative regulation of MAPK3 expression using miRNAs has led to therapeutic effects in cancer. Objectives. The present study performed molecular docking and dynamics simulation to identify potential MAPK3 inhibitors from natural flavonoids, possibly leading to drug development in cancer therapy. Methods. A computational drug discovery approach was performed using the AutoDock tool to identify potential MAPK3 inhibitors from 46 plant-based flavonoids. A cross-validation study was executed using the Schrödinger Maestro docking tool. Molecular dynamics (MD) was executed to evaluate the stability of docked poses between the top-ranked compounds and the MAPK3 catalytic domain. Interactions among the most potent MAPK3 inhibitors and residues within the receptor’s active site were studied using the BIOVIA Discovery Studio Visualizer before and after 100 ns MD simulations. Results. Kaempferol 3-rutinoside-4′-glucoside, kaempferol 3-rutinoside-7-sophoroside, rutin, and vicenin-2 exhibited a magnificent binding affinity to the receptor’s active site. In addition, the stability of the docked poses of these compounds seemed to be stable after ∼45 ns computer simulations. Conclusion. The present study suggests that kaempferol 3-rutinoside-4′-glucoside, kaempferol 3-rutinoside-7-sophoroside, rutin, and vicenin-2 could strongly bind to the MAPK3 catalytic site and could be assigned as a potent inhibitor for MAPK3. These findings may be helpful in the treatment of various cancers. However, further validation experiments are needed.
format Article
id doaj-art-a8f36248dc22473eb3e6d3eee8d544e6
institution Kabale University
issn 1687-8779
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series International Journal of Analytical Chemistry
spelling doaj-art-a8f36248dc22473eb3e6d3eee8d544e62025-02-03T06:47:17ZengWileyInternational Journal of Analytical Chemistry1687-87792023-01-01202310.1155/2023/8899240Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery ApproachAmir Taherkhani0Parita Khodadadi1Lida Samie2Zahra Azadian3Zeynab Bayat4Research Center for Molecular MedicineDepartment of Oral and Maxillofacial MedicineDepartment of Oral and Maxillofacial MedicineResearch Center for Molecular MedicineDepartment of Oral and Maxillofacial MedicineBackground. Mitogen-activated protein kinase 3 (MAPK3) mediates the onset, progression, metastasis, drug resistance, and poor prognosis in various malignancies, including glioma, liver, ovarian, thyroid, lung, breast, gastric, and oral cancers. Negative regulation of MAPK3 expression using miRNAs has led to therapeutic effects in cancer. Objectives. The present study performed molecular docking and dynamics simulation to identify potential MAPK3 inhibitors from natural flavonoids, possibly leading to drug development in cancer therapy. Methods. A computational drug discovery approach was performed using the AutoDock tool to identify potential MAPK3 inhibitors from 46 plant-based flavonoids. A cross-validation study was executed using the Schrödinger Maestro docking tool. Molecular dynamics (MD) was executed to evaluate the stability of docked poses between the top-ranked compounds and the MAPK3 catalytic domain. Interactions among the most potent MAPK3 inhibitors and residues within the receptor’s active site were studied using the BIOVIA Discovery Studio Visualizer before and after 100 ns MD simulations. Results. Kaempferol 3-rutinoside-4′-glucoside, kaempferol 3-rutinoside-7-sophoroside, rutin, and vicenin-2 exhibited a magnificent binding affinity to the receptor’s active site. In addition, the stability of the docked poses of these compounds seemed to be stable after ∼45 ns computer simulations. Conclusion. The present study suggests that kaempferol 3-rutinoside-4′-glucoside, kaempferol 3-rutinoside-7-sophoroside, rutin, and vicenin-2 could strongly bind to the MAPK3 catalytic site and could be assigned as a potent inhibitor for MAPK3. These findings may be helpful in the treatment of various cancers. However, further validation experiments are needed.http://dx.doi.org/10.1155/2023/8899240
spellingShingle Amir Taherkhani
Parita Khodadadi
Lida Samie
Zahra Azadian
Zeynab Bayat
Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach
International Journal of Analytical Chemistry
title Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach
title_full Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach
title_fullStr Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach
title_full_unstemmed Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach
title_short Flavonoids as Strong Inhibitors of MAPK3: A Computational Drug Discovery Approach
title_sort flavonoids as strong inhibitors of mapk3 a computational drug discovery approach
url http://dx.doi.org/10.1155/2023/8899240
work_keys_str_mv AT amirtaherkhani flavonoidsasstronginhibitorsofmapk3acomputationaldrugdiscoveryapproach
AT paritakhodadadi flavonoidsasstronginhibitorsofmapk3acomputationaldrugdiscoveryapproach
AT lidasamie flavonoidsasstronginhibitorsofmapk3acomputationaldrugdiscoveryapproach
AT zahraazadian flavonoidsasstronginhibitorsofmapk3acomputationaldrugdiscoveryapproach
AT zeynabbayat flavonoidsasstronginhibitorsofmapk3acomputationaldrugdiscoveryapproach